BAYN.DE Headlines | BAYER N Stock - Yahoo! Finance

Fri, May 24, 2013, 2:57PM EDT - U.S. Markets close in 1 hr 3 mins

Dow

0.03% Nasdaq

0.18%

More On BAYN.DE

Quotes

Summary
Order Book
Options
Historical Prices

Charts

News & Info

Headlines
Press Releases
Company Events
Message Boards

Company

Profile
Key Statistics
SEC Filings
Competitors
Industry
Components

Analyst Coverage

Analyst Opinion
Analyst Estimates
Research Reports

Ownership

Major Holders
Insider Transactions
Insider Roster

Financials

Bayer AG (BAYN.DE)

-XETRA

84.46 0.55(0.66%) 11:35AM EDT

Add to Portfolio

Headlines

Get Headlines for:

Thursday, May 23, 2013

IPhone Urinalysis Draws First FDA Inquiry of Medical Appsat Bloomberg (Thu, May 23)

Tuesday, May 21, 2013

Deutsche Bank Seeks to Avoid Law Suits With Board Changesat Bloomberg (Tue, May 21)
Regeneron, Sanofi asthma drug seen as potential game changerat Reuters (Tue, May 21)
German stocks - Factors to watch on May 21at Reuters (Tue, May 21)

Monday, May 20, 2013

Regeneron settles all pending litigation with Roche's Genentechat Reuters (Mon, May 20)
Bayer says lung drug shows promise in prolonged trialat Reuters (Mon, May 20)

Friday, May 17, 2013

EU watchdog backs Bayer acne drug for certain patientsat Reuters (Fri, May 17)

Thursday, May 16, 2013

[$$] Dow Chemical to Appeal Judgmentat The Wall Street Journal (Thu, May 16)
Bayer to acquire herbal medicine maker Steigerwaldat Reuters (Thu, May 16)
Algeta Surges to Record After Prostate Cancer Drug Approvalat Bloomberg (Thu, May 16)
German stocks - Factors to watch on May 16at Reuters (Thu, May 16)
NORDIC STOCKS - Factors to watch on May 16at Reuters (Thu, May 16)

Wednesday, May 15, 2013

[$$] Bayer Gets FDA Approval for Advanced Prostate Cancer Drugat The Wall Street Journal (Wed, May 15)
Bayer, Algeta win FDA approval for prostate cancer drugat Reuters (Wed, May 15)
Bayer, Algeta Win U.S. Approval for Prostate Cancer Drugat Bloomberg (Wed, May 15)
German chemical sector still sees 2 pct growth in 2013at Reuters (Wed, May 15)
Bayer starts Phase III trial on regorafenib in liver cancerat Reuters (Wed, May 15)

Tuesday, May 14, 2013

U.S. urged to take tougher line on Indian trade practicesat Reuters (Tue, May 14)
A taste for defensives sours prospects for European stocksat Reuters (Tue, May 14)
Bayer Communications Chief Schade to Run Leverkusen Soccer Clubat Bloomberg (Tue, May 14)

Older Headlines

Add BAYN.DE News to My Yahoo!

Copyright © 2009 Yahoo! All rights reserved.

Quotes are real-time for NASDAQ, NYSE, and NYSE MKT. See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc.